InStride Health: A Beacon of Hope for Pediatric Mental Health
April 4, 2024, 9:35 pm
InStride Health, a beacon of hope for pediatric mental health, recently secured $30M in Series B funding to expand access to high-quality, evidence-based care for children and adolescents struggling with anxiety and OCD. Led by CEO John Voith, the company's mission is to provide affordable and accessible treatment to young people in need, bridging the gap in pediatric mental healthcare. With a focus on evidence-based practices like Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), InStride Health is on a mission to make a difference in the lives of kids, teens, and young adults facing mental health challenges. Through their innovative care model and dedicated team of experts, InStride Health is paving the way for a brighter future for the next generation.